Likewise, the dramatic reduction in the cost of gene sequencing, from roughly $40 million per human genome in 2003 to about $5,000 today, together with a rapid increase in computational power, is boosting the speed, accuracy, and robustness of medical diagnostic tests. That promises not only more timely and effective therapies for cancer, but also similar advances against other currently intractable diseases.
类似地，基因测序成本的显著降低——从每人2003年的4 000万美元左右下降到今天的5 000美元左右——以及计算能力的快速增加正在提高医学诊断测试的速度、准确性和鲁棒性。这不但能带来更及时、更有效的癌症疗法，也能给其他目前的疑难杂症的医治带来类似的进步。